Russell Investments Group
YMAB

Russell Investments Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Russell Investments Group’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188
Closed -$2.27K – 3812
2024
Q2 		$2.27K Buy
188
+163
+652% +$2.2K ﹤0.01% 3331
2024
Q1 		$407 Sell
25
-16,903
-100% -$228K ﹤0.01% 3237
2023
Q4 		$115K Sell
16,928
-9,725
-36% -$56.2K ﹤0.01% 2534
2023
Q3 		$145K Sell
26,653
-1,573
-6% -$9.16K ﹤0.01% 2549
2023
Q2 		$192K Buy
28,226
+16,414
+139% +$123K ﹤0.01% 2484
2023
Q1 		$59.2K Buy
11,812
+10,996
+1,348% +$44.9K ﹤0.01% 2692
2022
Q4 		$3.98K Hold
816
– – ﹤0.01% 2872
2022
Q3 		$11K Buy
+816
New +$13.5K ﹤0.01% 2857
2022
Q1 		– Sell
-64,404
Closed -$1.04M – 2955
2021
Q4 		$1.04M Buy
64,404
+28,124
+78% +$601K ﹤0.01% 2126
2021
Q3 		$1.03M Buy
36,280
+33,304
+1,119% +$1.05M ﹤0.01% 2171
2021
Q2 		$100K Hold
2,976
– – ﹤0.01% 3056
2021
Q1 		$89K Buy
+2,976
New +$122K ﹤0.01% 2993
2020
Q4 		– Sell
-3,953
Closed -$151K – 3212
2020
Q3 		$151K Hold
3,953
– – ﹤0.01% 2882
2020
Q2 		$170K Buy
+3,953
New +$149K ﹤0.01% 2753

Other funds holding YMAB

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Russell Investments Group's YMAB Position: Q3 2024 in Review

Russell Investments Group sold out of Y-mAbs Therapeutics (YMAB) in Q3 2024, closing a stake of 188 shares — an estimated $2.27K sold.

Russell Investments Group first reported a position in YMAB in Q2 2020 and held it in 14 quarters. The position peaked at $1.04M in Q4 2021. 105 funds tracked by Wall St. Rank hold YMAB as of Q3 2024.

  • Russell Investments Group reported no remaining Y-mAbs Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 188 Y-mAbs Therapeutics shares in Q3 2024, an estimated $2.27K.
  • Russell Investments Group first reported a position in Y-mAbs Therapeutics in Q2 2020 and held it in 14 quarters.
  • Russell Investments Group's Y-mAbs Therapeutics position peaked at $1.04M in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.